整合医疗系统内糖尿病筛查的多层次变异
本研究为美国整合医疗系统内的回顾性队列研究,纳入2010至2015年间18-64岁、至少两次门诊就诊且无糖尿病诊断的初级保健患者56818例,采用三层模型分析患者、医生和诊所层面的筛查变异。结果显示70%患者完成筛查,诊所间差异近两倍(51-92%,P<0.001),调整后医生和诊所层面仍存在近两倍变异(中位OR 1.97;组内相关系数0.13)。作者认为筛查实践变异大,需临床决策支持和系统层面干预。
要点
- 56818例患者中70%完成糖尿病筛查,诊所间筛查率差异近两倍(51-92%,P<0.001)。
- 符合ADA和USPSTF筛查标准者中约四分之三被筛查,诊所间差异近两倍(ADA 53-92%;USPSTF 49-93%)。
- 调整患者、医生和诊所因素后,医生和诊所层面筛查变异仍近两倍(中位OR 1.97;组内相关系数0.13)。
核心结论
- 筛查实践变异广泛,仅部分可由电子健康记录中患者、医生和诊所因素解释。
- 作者认为需要临床决策支持和系统层面干预以优化筛查实践。
研究设计与样本
- 美国整合医疗系统内12家诊所的回顾性队列研究。
- 纳入2010至2015年间18-64岁、至少两次门诊就诊且电子健康记录无糖尿病诊断的初级保健患者56818例。
- 采用三层分层模型评估患者、医生和诊所层面的筛查变异。
- 糖尿病筛查定义为有金标准筛查试验结果。
主要发现
- 56818例患者中70%完成糖尿病筛查,诊所间差异近两倍(51-92%;P<0.001)。
- 符合ADA筛查标准者占69%,其中约四分之三被筛查,诊所间差异近两倍(53-92%)。
- 符合USPSTF筛查标准者占36%,其中约四分之三被筛查,诊所间差异近两倍(49-93%)。
- ADA与USPSTF筛查对糖尿病(11% vs. 9%)和糖尿病前期(38% vs. 36%)的检出率相似。
- 近70%不符合指南筛查条件的患者也接受了检测;USPSTF指南较ADA指南漏诊更多糖尿病(6% vs. 3%)和糖尿病前期(26% vs. 19%)。
关键数值与推荐
- ADA筛查标准覆盖69%患者,USPSTF筛查标准覆盖36%患者。
- ADA与USPSTF筛查的糖尿病检出率分别为11%和9%,糖尿病前期检出率分别为38%和36%。
- USPSTF指南漏诊糖尿病6%、糖尿病前期26%;ADA指南漏诊糖尿病3%、糖尿病前期19%。
- 调整患者、医生和诊所因素并考虑聚类后,医生和诊所层面筛查变异仍近两倍(中位OR 1.97;组内相关系数0.13)。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Variation in diabetes screening in clinical practice is poorly described. We examined the interplay of patient, provider, and clinic factors explaining variation in diabetes screening within an integrated health care system in the U.S. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study of primary care patients aged 18-64 years with two or more outpatient visits between 2010 and 2015 and no diagnosis of diabetes according to electronic health record (EHR) data. Hierarchical three-level models were used to evaluate multilevel variation in screening at the patient, provider, and clinic levels across 12 clinics. Diabetes screening was defined by a resulted gold standard screening test. RESULTS: Of 56,818 patients, 70% completed diabetes screening with a nearly twofold variation across clinics (51-92%; P < 0.001). Of those meeting American Diabetes Association (ADA) (69%) and U.S. Preventive Services Task Force (USPSTF) (36%) screening criteria, three-quarters were screened with a nearly twofold variation across clinics (ADA 53-92%; USPSTF 49-93%). The yield of ADA and USPSTF screening was similar for diabetes (11% vs. 9%) and prediabetes (38% vs. 36%). Nearly 70% of patients not eligible for guideline-based screening were also tested. The USPSTF guideline missed more cases of diabetes (6% vs. 3%) and prediabetes (26% vs. 19%) than the ADA guideline. After adjustment for patient, provider, and clinic factors and accounting for clustering, twofold variation in screening by provider and clinic remained (median odds ratio 1.97; intraclass correlation 0.13). CONCLUSIONS: Screening practices vary widely and are only partially explained by patient, provider, and clinic factors available in the EHR. Clinical decision support and system-level interventions are needed to optimize screening practices.
引用
- Obinwa U, Pérez A, Lingvay I, et al. Multilevel Variation in Diabetes Screening Within an Integrated Health System. Diabetes Care. 2020. PMID: 32139383. doi:10.2337/dc19-1622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。